Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Operating Margin (2022 - 2025)

Historic Operating Margin for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to 13.69%.

  • Indivior Pharmaceuticals' Operating Margin rose 22900.0% to 13.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.24%, marking a year-over-year increase of 156900.0%. This contributed to the annual value of 1.94% for FY2024, which is 119700.0% up from last year.
  • Indivior Pharmaceuticals' Operating Margin amounted to 13.69% in Q3 2025, which was up 22900.0% from 23.84% recorded in Q2 2025.
  • Indivior Pharmaceuticals' 5-year Operating Margin high stood at 28.51% for Q2 2022, and its period low was 107.05% during Q4 2022.
  • Moreover, its 4-year median value for Operating Margin was 21.29% (2023), whereas its average is 1.13%.
  • Examining YoY changes over the last 5 years, Indivior Pharmaceuticals' Operating Margin showed a top increase of 1275300bps in 2023 and a maximum decrease of -916700bps in 2023.
  • Indivior Pharmaceuticals' Operating Margin (Quarter) stood at 107.05% in 2022, then surged by 119bps to 20.48% in 2023, then fell by -25bps to 15.44% in 2024, then decreased by -11bps to 13.69% in 2025.
  • Its last three reported values are 13.69% in Q3 2025, 23.84% for Q2 2025, and 24.81% during Q1 2025.